Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcriptomic profiling of three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) in response to ALK inhibition


ABSTRACT: Anaplastic Lymphoma Kinase (ALK) is a tyrosine kinase receptor which is a clinical target of major interest in cancer, including neuroblastoma. To better understand ALK signaling, three different neuroblastoma cell lines (CLB-BAR, CLB-GE and SK-N-AS) were cultured for 1hr and 24hrs in control conditions or after treatment with the ALK inhibitors crizotinib or lorlatinib. RNA-Seq experiments were performed to determine the expression changes resulting from ALK inhibition. Together with parallel phosphoproteomic experiments, these data unveil several important conserved oncogenic pathways in neuroblastoma.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Homo sapiens

SUBMITTER: Jimmy Van den Eynden 

PROVIDER: E-MTAB-6654 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2020-02-14 | GSE130022 | GEO
2022-12-13 | E-MTAB-11883 | biostudies-arrayexpress
| PRJEB26451 | ENA
2014-07-01 | E-MTAB-2253 | biostudies-arrayexpress
2018-11-27 | PXD011187 | Pride
2013-03-03 | E-MTAB-1367 | biostudies-arrayexpress
2015-01-10 | E-GEOD-34984 | biostudies-arrayexpress
2017-11-08 | E-MTAB-6144 | biostudies-arrayexpress
2023-02-23 | E-MTAB-12588 | biostudies-arrayexpress
2023-02-23 | E-MTAB-12586 | biostudies-arrayexpress